Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
复制标题
非小细胞肺癌异种移植物中产生的淋巴增殖性肿瘤的表型分析
DOI:
10.1101/2023.01.24.520089
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Pearce D
中科院分区:
文献类型:
--
作者:
Pearce D
BackgroundPatient-derived xenograft (PDX) models involve the engraftment of tumour tissue in immunocompromised mice and represent an important pre-clinical oncology research method. A limitation of non-small cell lung cancer (NSCLC) PDX model derivation in NOD-scidIL2Rgammanull(NSG) mice is that a subset of initial engraftments are of lymphocytic, rather than tumour origin.MethodsThe immunophenotype of lymphoproliferations arising in the lung TRACERx PDX pipeline were characterised. To present the histology data herein, we developed a Python-based tool for generating patient-level pathology overview figures from whole-slide image files; PATHOverview is available on GitHub (https://github.com/EpiCENTR-Lab/PATHOverview).ResultsLymphoproliferations occurred in 17.8% of lung adenocarcinoma and 10% of lung squamous cell carcinoma transplantations, despite none of these patients having a prior or subsequent clinical history of lymphoproliferative disease. Lymphoproliferations were predominantly human CD20+ B cells and had the immunophenotype expected for post-transplantation diffuse large B cell lymphoma with plasma cell features. All lymphoproliferations expressed Epstein-Barr-encoded RNAs (EBER). Analysis of immunoglobulin light chain gene rearrangements in three tumours where multiple tumour regions had resulted in lymphoproliferations suggested that each had independent clonal origins.DiscussionOverall, these data suggest that B cell clones with lymphoproliferative potential are present within primary NSCLC tumours, and that these are under continuous immune surveillance. Since these cells can be expanded following transplantation into NSG mice, our data highlight the value of quality control measures to identify lymphoproliferations within xenograft pipelines and support the incorporation of strategies to minimise lymphoproliferations during the early stages of xenograft establishment pipelines.
登录
查看更多内容
影响因子:
11.4
作者:
Langerak, A. W.;Molina, T. J.;Van Krieken, J. H. J. M.
通讯作者:
Van Krieken, J. H. J. M.
DOI:
10.1073/pnas.78.2.805
发表时间:
1981-01-01
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES
影响因子:
--
作者:
LERNER, MR;ANDREWS, NC;STEITZ, JA
通讯作者:
STEITZ, JA
影响因子:
15.3
作者:
Giachino, Claudia;Padovan, Elisabetta;Lanzavecchia, Antonio
通讯作者:
Lanzavecchia, Antonio
影响因子:
5.3
作者:
Kang, Han Na;Choi, Jae Woo;Kim, Hye Ryun
通讯作者:
Kim, Hye Ryun
影响因子:
6.4
作者:
Wang, Dennis;Nhu-An Pham;Tsao, Ming-Sound
通讯作者:
Tsao, Ming-Sound